Cargando…
Residual sleep disturbance and risk of relapse during the continuation/maintenance phase treatment of major depressive disorder with the selective serotonin reuptake inhibitor fluoxetine
BACKGROUND: Relapse of major depressive disorder (MDD) is a common clinical problem. This study was designed to determine whether residual sleep disturbance (insomnia and hypersomnia) predict risk of relapse during the continuation and maintenance treatment of MDD. METHODS: A total of 570 patients w...
Autores principales: | Yang, Huaiyu, Sinicropi-Yao, Lara, Chuzi, Sarah, Youn, Soo Jeong, Clain, Alisabet, Baer, Lee, Chen, Ying, McGrath, Patrick J, Fava, Maurizio, Papakostas, George I |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2837657/ https://www.ncbi.nlm.nih.gov/pubmed/20187924 http://dx.doi.org/10.1186/1744-859X-9-10 |
Ejemplares similares
-
Behavioral destabilization induced by the selective serotonin reuptake inhibitor fluoxetine
por: Kobayashi, Katsunori, et al.
Publicado: (2011) -
Treatment with the selective serotonin reuptake inhibitor, fluoxetine, attenuates the fish hypoxia response
por: Panlilio, Jennifer M., et al.
Publicado: (2016) -
Selective serotonin reuptake inhibitor use associates with apathy among depressed elderly: a case-control study
por: Wongpakaran, Nahathai, et al.
Publicado: (2007) -
Effects of a Selective Serotonin Reuptake Inhibitor, Fluoxetine, on Counterregulatory Responses to Hypoglycemia in Healthy Individuals
por: Briscoe, Vanessa J., et al.
Publicado: (2008) -
In utero and lactational exposure to the Selective Serotonin Reuptake Inhibitor fluoxetine compromises pup bones at weaning
por: Weaver, Samantha R., et al.
Publicado: (2019)